Cervical cancer, Clear cell cancer, Ovarian cancer, Secondary cancers, Womb (uterine or endometrial) cancer
Results
Phase 2
This trial looked at an immunotherapy drug for people with advanced clear cell ovarian , endometrial and cervical cancer who had already had treatment.
The trial was open for people to join between 2019 and 2021. The team published the main results in 2025.
Recruitment start: 4 March 2019
Recruitment end: 20 October 2021
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Rebecca Kristeleit
Merck, Sharp and Dohme
University College London (UCL)
Cancer Research UK & UCL Cancer Trials Centre
Queen Mary University of London
National Institute for Health and Care Research
Last reviewed: 11 September 2025
CRUK internal database number: 16265
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
